# An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

> **NCT07578363** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Alcon Research** · enrollment: 178 (estimated)

## Conditions studied

- Ocular Hyperemia

## Interventions

- **DRUG:** Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT07578363
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2026-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07578363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07578363, "An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT07578363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*